Cite
HARVARD Citation
Chen, H. et al. (2020). Neobavaisoflavone inhibits osteoclastogenesis through blocking RANKL signalling‐mediated TRAF6 and c‐Src recruitment and NF‐κB, MAPK and Akt pathways. Journal of cellular and molecular medicine. 24 (16), pp. 9067-9084. [Online].